Biovaxys Technology Corp (BIOV.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
(Values in thousands)
| 10-2024 | 10-2023 | 10-2022 | 10-2021 | 10-2020 | |
| Operating Expenses | 3,296 | 6,453 | 4,082 | 6,442 | 1,098 |
| Operating Income | -3,296 | -6,453 | -4,082 | -6,442 | -1,098 |
| Other Income | -659 | -1,234 | -7,646 | -16 | -4 |
| Pre-tax Income | -3,955 | -7,687 | -11,727 | -6,458 | -1,103 |
| Net Income Continuous | -3,955 | -7,687 | -11,727 | -6,458 | -1,103 |
| Net Income Discontinuous | N/A | N/A | N/A | 0 | -72 |
| Net Income | $-3,955 | $-7,687 | $-11,727 | $-6,458 | $-1,174 |
| EPS Basic Total Ops | -0.20 | -0.60 | -1.20 | -0.78 | -0.40 |
| EPS Basic Continuous Ops | -0.20 | -0.60 | -1.20 | -0.78 | -0.39 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 0.00 | -0.01 |
| EPS Diluted Total Ops | -0.20 | -0.60 | -1.20 | -0.78 | -0.40 |
| EPS Diluted Continuous Ops | -0.20 | -0.60 | -1.20 | -0.78 | -0.39 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 0.00 | -0.01 |
| EBITDA(a) | $-3,296 | $-6,453 | $-4,082 | $-6,442 | $-1,098 |